» Articles » PMID: 18096503

A Comprehensive Profile of Brain Enzymes That Hydrolyze the Endocannabinoid 2-arachidonoylglycerol

Overview
Journal Chem Biol
Publisher Elsevier
Date 2007 Dec 22
PMID 18096503
Citations 530
Authors
Affiliations
Soon will be listed here.
Abstract

Endogenous ligands for cannabinoid receptors ("endocannabinoids") include the lipid transmitters anandamide and 2-arachidonoylglycerol (2-AG). Endocannabinoids modulate a diverse set of physiological processes and are tightly regulated by enzymatic biosynthesis and degradation. Termination of anandamide signaling by fatty acid amide hydrolase (FAAH) is well characterized, but less is known about the inactivation of 2-AG, which can be hydrolyzed by multiple enzymes in vitro, including FAAH and monoacylglycerol lipase (MAGL). Here, we have taken a functional proteomic approach to comprehensively map 2-AG hydrolases in the mouse brain. Our data reveal that approximately 85% of brain 2-AG hydrolase activity can be ascribed to MAGL, and that the remaining 15% is mostly catalyzed by two uncharacterized enzymes, ABHD6 and ABHD12. Interestingly, MAGL, ABHD6, and ABHD12 display distinct subcellular distributions, suggesting that they may control different pools of 2-AG in the nervous system.

Citing Articles

The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test.

Kruk-Slomka M, Dzik A, Biala G Molecules. 2025; 30(4).

PMID: 40005177 PMC: 11857936. DOI: 10.3390/molecules30040867.


The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles.

Straub V, Barti B, Tandar S, Stevens A, van Egmond N, van der Wel T Proc Natl Acad Sci U S A. 2025; 122(8):e2421717122.

PMID: 39977325 PMC: 11873938. DOI: 10.1073/pnas.2421717122.


An S-acylated N-terminus and a conserved loop regulate the activity of the ABHD17 deacylase.

Holme S, Sapia J, Davey M, Vanni S, Conibear E J Cell Biol. 2025; 224(4).

PMID: 39951021 PMC: 11827582. DOI: 10.1083/jcb.202405042.


A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype.

Ma M, Ma J, Lian Y, Wu X, Wang W, Rong W Mol Genet Genomic Med. 2025; 13(2):e70055.

PMID: 39910854 PMC: 11799048. DOI: 10.1002/mgg3.70055.


Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery.

Shen S, Wu C, Yang Z, Wang K, Shao Z, Yan W Acta Pharmacol Sin. 2025; .

PMID: 39910211 DOI: 10.1038/s41401-024-01472-9.


References
1.
Gulyas A, Cravatt B, Bracey M, Dinh T, Piomelli D, Boscia F . Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004; 20(2):441-58. DOI: 10.1111/j.1460-9568.2004.03428.x. View

2.
Cravatt B, Giang D, Mayfield S, Boger D, Lerner R, Gilula N . Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996; 384(6604):83-7. DOI: 10.1038/384083a0. View

3.
Varvel S, Cravatt B, Engram A, Lichtman A . Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task. J Pharmacol Exp Ther. 2005; 317(1):251-7. DOI: 10.1124/jpet.105.095059. View

4.
McKinney M, Cravatt B . Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005; 74:411-32. DOI: 10.1146/annurev.biochem.74.082803.133450. View

5.
Alexander J, Cravatt B . The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J Am Chem Soc. 2006; 128(30):9699-704. DOI: 10.1021/ja062999h. View